Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity

Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity

10.1111/bcp.13008

Saved in:
Bibliographic Details
Main Authors: Aminkeng, Folefac, Ross, Colin JD, Rassekh, Shahrad R, Hwang, Soomi, Rieder, Michael J, Bhavsar, Amit P, Smith, Anne, Sanatani, Shubhayan, Gelmon, Karen A, Bernstein, Daniel, Hayden, Michael R, Amstutz, Ursula, Carleton, Bruce C
Other Authors: MEDICINE
Format: Review
Language:English
Published: WILEY 2022
Subjects:
Science & Technology
Life Sciences & Biomedicine
Pharmacology & Pharmacy
anthracycline
cardiotoxicity
heart-failure
guidelines
pharmacogenomics
cancer
ACUTE LYMPHOBLASTIC-LEUKEMIA
ADVANCED BREAST-CANCER
CONTINUOUS INTRAVENOUS-INFUSION
DOXORUBICIN-INDUCED CARDIOTOXICITY
LIPOSOME-ENCAPSULATED DOXORUBICIN
ADRIAMYCIN-INDUCED CARDIOMYOPATHY
CONGESTIVE-HEART-FAILURE
NON-HODGKIN-LYMPHOMA
LONG-TERM SURVIVORS
B-CELL LYMPHOMA
Online Access:https://scholarbank.nus.edu.sg/handle/10635/235077
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English

Similar Items

Similar Items